Table 3.
Heart and brain study of enteroviral infections in all age groups
| 0–90 days (n = 44) |
> 90 days (n = 17) |
Total (n = 61) |
||||
|---|---|---|---|---|---|---|
| Performed, n | Abnormal, n | Performed, n | Abnormal, n | Performed, n | Abnormal, n | |
| ECG recording, n (%) | 44 | 1 (2.3)a | 17 | 0 | 61 | 1 (1.6) |
| Heart US study, n (%) | 30 | 3 (10) b | 7 | 0 | 37 | 3 (8.1) |
| Brain US study, n (%) | 27 | 3 (11.1) c | – | 27 | 3 (11.1) | |
| Brain MRI, n (%) | 8 | 3 (37.5) d | 1 | 0 | 9 | 3 (33.3) |
| Brain CT, n (%) | – | 7 | 0 | 7 | 0 | |
| EEG recording, n (%) | 10 | 3 (30) | 8 | 2 (25) | 18 | 5 e (27.8) |
CT Computed tomography, ECG Electrocardiogram, EEG Electroencephalography, MRI Magnetic resonance imaging, US Ultrasound
a Abnormal repolarization
b Low ejection fraction (n = 1), hyperechoic interventricular septum (n = 1), pericardial effusions (n = 1)
c Hyperechoic spots in the white matter and basal ganglia (n = 2), thinned brain ventricle (n = 1)
d Hyper-intense signal areas of brain white matter in T1 or T2-weighted images
e Anterior slow dysrhythmia (n = 4), status epilepticus, (n = 1), suppression burst patterns (n = 1) excess of theta rhythm (n = 1)